Why XNCR? Xencor, Inc. Analysis, Price & AI Insights | Whystock
XNCR
$12.69+0.76 (+6.37%)
Market ClosedLast close May 1
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered antibodies for the treatment of cancer and autoimmune diseases.